Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Top Ten Most Innovative Healthcare Companies of 2015
Medical Entrepreneurs – Take Note!
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: http://www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: http://www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
***
Recently, I was reading the limited partner quarterly updates for a fund where I’m an investor. In the update, the author highlighted that the fund had reviewed 1,000 potential deals last year and invested in four companies. At a ratio of 250:1, it’s clear that there are many more startups trying to raise a Series A than there are Series A investments (see the Series A crunch talked about four years ago).
Here’s how the investment process might work at a venture fund:
- 250 deals reviewed
- 25 one-on-one pitches (where the entrepreneur pitches a single partner)
- 5 full partner pitches (where all the partners hear the pitch)
- 2 term sheets
- 1 investment
Raising money is much harder than most entrepreneurs expect. With funds seeing so many opportunities, but only being able to invest in 1-2 companies per year per investor, it’s clear that most entrepreneurs will feel rejected when out raising…
View original post 17 more words
Share this:
Filed under: Career Development, Research & Development | Tagged: 100 healthcare innovators, David Cummings, Entrepreneurs, start-ups |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Startups Vie to Build an “Uber” for Health Care
Heal is one of several startups putting a high-tech spin on old-fashioned house calls—or “in-person visits,” since they can take place anywhere.
http://www.msn.com/en-us/money/companies/startups-vie-to-build-an-uber-for-health-care/ar-BBlDbVa?ocid=iehp
The services provide a range of nonemergency medical care—from giving flu shots to treating strep throats and stitching lacerations—much like a mobile urgent-care clinic.
Dr. David Edward Marcinko MBA CMP™
http://www.CertifiedMedicalPlanner.org
LikeLike
Scanadu
Scanadu, a personal health scanner company that shattered records on Indiegogo a few years ago, has raised $6.5 million according to an SEC filing.
The new funding comes at a time when the company is under fire for what many customers see as an unsatisfactory end to its FDA usability trial, as well as Scanadu’s elimination from the Qualcomm Tricorder X Prize.
All these developments raise big questions about the future of the Silicon Valley-based scanning company, if not the future of the tricorder itself as a feasible commercial product. It seems clear that the company has had more trouble than it expected getting the go-ahead from the FDA. Whether the new funding will be enough to help the company surmount that challenge remains to be seen.
Hope R. Hetico RN MHA
LikeLike